Advanced search
Companies (174)
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...
Capitalization | 8 341 M USD |
---|---|
Change | -0.47% |
1-year price change | -24.50% |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (neb ...
Capitalization | 12 098 M USD |
---|---|
Change | -0.30% |
1-year price change | +23.46% |
Hon Kwok Land Investment Company, Limited is a Hong Kong-based investment holding company principally engaged in property businesses. The Company operates through three segments. The Property Development segment is engaged in property development. The Pro ...
Capitalization | 159 M USD |
---|---|
Change | -0.58% |
1-year price change | +21.28% |
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for opera ...
Capitalization | 4 879 M USD |
---|---|
Change | -0.42% |
1-year price change | -15.05% |
Neola Medical AB, formerly GPX Medical AB is a Sweden-based company that is involved in development of medical instruments. The Company's business concept is to commercialize the Company's medical technology product for continuous lung monitoring based on ...
Capitalization | 13 M USD |
---|---|
Change | +2.51% |
1-year price change | +4.62% |
Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solut ...
Capitalization | 41 M USD |
---|---|
Change | 0.00% |
1-year price change | -22.78% |
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritin ...
Capitalization | 6 687 M USD |
---|---|
Change | -0.26% |
1-year price change | +15.12% |
ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company's technology comprises an antibody t ...
Capitalization | 8 359 M USD |
---|---|
Change | -.--% |
1-year price change | +5.33% |
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions i ...
Capitalization | 4 M USD |
---|---|
Change | -.--% |
1-year price change | -100.00% |
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company; Synairgen Inc. and Synairgen Research (Ireland) Limited. The Company is developing SNG001, an investigat ...
Capitalization | 16 M USD |
---|---|
Change | -7.15% |
1-year price change | -0.38% |
- Stock Market
- Advanced search
- Kwok Lung Hongchoy
- Company Profiles